(BAYRY) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
|
0%
agree
0 votes
|
FDA approval |
May 25, 2013
(Stock Blog Hub,
5/3/13)
Monsanto Company (MON), an agricultural services provider, recently entered into a contract with Bayer CropScience, a wing of Germany based Bayer AG. The deal relates to the licensing...(read more)
(Stock Blog Hub,
12/31/12)
We are reverting to a Neutral recommendation on Bayer (BAYRY) as we believe that all the positive news that led to our previous Outperform recommendation on the stock are reflected in the current...(read more)
(Value Investing,
9/13/12)
In its attempts to save its troubled consumer health and manufacturing operations, renowned health care big wig Johnson & Johnson (NYSE:JNJ) is making new hires. Johnson...(read more)
Bayer AG (BAYRY) Company Overview
There is no analysis for BAYRY yet. But you can go to Wikinvest to help create one!
What's in this BAYRY analysis on Wikinvest...
- Company Overview
- Business & Financial Metrics[1]
- Business Segments
- HealthCare[2]
- CropSciene[3]
- MaterialScience[4]
- Trends and Forces
- Generic drugs limit brand name drug use and drive down prices
- Product development costs lower profit margins
- Health insurance limits the use of expensive pharmaceuticals
- Biofuel production boosts the demand for crop-enhancement products
- Competition
- References
